Published in JAMA on August 25, 1978
Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev (2005) 14.71
Melioidosis: the tip of the iceberg? Clin Microbiol Rev (1991) 5.95
Intracellular survival of Burkholderia pseudomallei. Infect Immun (1996) 3.56
Intensity of rainfall and severity of melioidosis, Australia. Emerg Infect Dis (2003) 3.41
Identification and characterization of a two-component regulatory system involved in invasion of eukaryotic cells and heavy-metal resistance in Burkholderia pseudomallei. Infect Immun (1997) 1.14
Protection against heterologous Burkholderia pseudomallei strains by dendritic cell immunization. Infect Immun (2006) 1.07
Pulmonary melioidosis in Cambodia: a prospective study. BMC Infect Dis (2011) 1.05
Burkholderia pseudomallei infection in a patient with diabetes presenting with multiple splenic abscesses and abscess in the foot: a case report. Cases J (2008) 0.99
Reactivation of latent melioidosis. Postgrad Med J (1990) 0.81
Melioidosis: Clinical impact and public health threat in the tropics. PLoS Negl Trop Dis (2017) 0.76
Extended use of nursing services in general practice. Br Med J (1967) 6.35
The practice nurse--a new look. Br Med J (1970) 5.16
Studies on the epidemiology of adverse drug reactions. V. Clinical factors influencing susceptibility. Ann Intern Med (1966) 5.11
Ligand binding to integrins. J Biol Chem (2000) 4.94
A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol (1983) 3.80
Diagnosis of chlamydial infection in women attending antenatal and gynecologic clinics. J Clin Microbiol (1987) 3.70
A novel vitronectin receptor integrin (alpha v beta x) is responsible for distinct adhesive properties of carcinoma cells. Cell (1989) 3.34
Reactions to tetanus toxoid. J Hyg (Lond) (1973) 3.33
Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci U S A (2001) 3.07
Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin. J Clin Invest (1971) 3.01
Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections. Antimicrob Agents Chemother (1989) 2.80
Local immune response in experimental pyelonephritis. J Clin Invest (1969) 2.73
The normal microbial flora. N Engl J Med (1982) 2.71
Oyster-associated hepatitis. Failure of shellfish certification programs to prevent outbreaks. JAMA (1975) 2.71
Localization of urinary-tract infections by detection of antibody-coated bacteria in urine sediment. N Engl J Med (1974) 2.63
Cultivation of Pneumocystis carinii with WI-38 cells. J Clin Microbiol (1979) 2.63
Eikenella corrodens, a recently recognized pathogen: infections in medical-surgical patients and in association with methylphenidate abuse. Medicine (Baltimore) (1974) 2.61
Cyclic adenosine 3',5'-monophosphate in human lymphocytes. Alterations after phytohemagglutinin stimulation. J Clin Invest (1971) 2.61
Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma. I. Leukocyte responsiveness to -adrenergic agents. J Clin Invest (1973) 2.42
RED: a red-cell antibody identification expert module. J Med Syst (1985) 2.24
Oyster-associated hepatitis: lessons from the Louisiana experience. Am J Epidemiol (1976) 2.23
General practitioners in hospital. Br Med J (1970) 2.22
New rat model of Pneumocystis carinii infection. J Clin Microbiol (1988) 2.21
Excess mortality associated with influenza in England and Wales. Int J Epidemiol (1977) 2.20
Current therapy for cutaneous melanoma. J Am Acad Dermatol (1995) 2.19
Frequency of immediate adverse effects associated with therapeutic apheresis. Transfusion (1999) 2.17
Typing of Pneumocystis carinii strains that infect humans based on nucleotide sequence variations of internal transcribed spacers of rRNA genes. J Clin Microbiol (1994) 2.17
MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res (2001) 2.12
Excess deaths attributable to influenza in England and Wales: age at death and certified cause. Int J Epidemiol (1983) 2.12
Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes. J Clin Microbiol (1998) 2.11
Nucleotide sequence variation in Pneumocystis carinii strains that infect humans. J Clin Microbiol (1993) 2.08
Bacterial infection-associated improvement of platelet counts in two patients with chronic and unresponsive idiopathic thrombocytopenic purpura with normal platelet survival studies. Br J Haematol (1995) 2.07
The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin. J Cell Biol (1990) 2.07
Duration of immunity after active immunisation against tetanus. Lancet (1969) 2.04
Progressive disseminated histoplasmosis. A prospective study of 26 patients. Ann Intern Med (1972) 1.99
Radioimmunoassay for prostaglandins. Science (1971) 1.99
Primary sarcomas of the mediastinum: results of therapy. J Thorac Cardiovasc Surg (1998) 1.96
Immune interactions with cells infected with herpes simplex virus: antibodies to radioiodinated surface antigens. J Immunol (1977) 1.94
The influence of a competitor on the geographic mosaic of coevolution between crossbills and lodgepole pine. Evolution (2001) 1.93
Antimicrobial susceptibility of Pneumocystis carinii in culture. Diagn Microbiol Infect Dis (1985) 1.78
THE CATEGORY OF TOPOLOGICAL OBJECTS. Proc Natl Acad Sci U S A (1961) 1.73
Alcohol and other substance abuse and impairment among physicians in residency training. Ann Intern Med (1992) 1.72
Activity of lipid-soluble inhibitors of dihydrofolate reductase against Pneumocystis carinii in culture and in a rat model of infection. Antimicrob Agents Chemother (1987) 1.72
Prevention of tetanus in the wounded. Br Med J (1975) 1.71
Observations on the collagen and proteinpolysaccharide complex of rabbit cornea stroma. J Cell Sci (1969) 1.70
HIV transmitted by sexual intercourse but not by kissing. Br Med J (Clin Res Ed) (1987) 1.70
Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med (1983) 1.70
Use of the 51 Cr release test to demonstrate patterns of antibody response in humans to herpesvirus types 1 and 2. J Immunol (1972) 1.68
Comparative study of district and community hospitals. Br Med J (1973) 1.67
Integrin-mediated cell adhesion: the extracellular face. J Biol Chem (1994) 1.66
Activity of clindamycin with primaquine against Pneumocystis carinii in vitro and in vivo. Antimicrob Agents Chemother (1988) 1.64
Growth and toxin production of Tetanus bacilli in vivo. J Med Microbiol (1974) 1.63
Pneumocystis carinii: improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.). Exp Parasitol (1990) 1.61
Risk of infection after penetrating abdominal trauma. N Engl J Med (1984) 1.60
The human gastric bactericidal barrier: mechanisms of action, relative antibacterial activity, and dietary influences. J Infect Dis (1989) 1.60
Dihydropteroate synthase polymorphisms in Pneumocystis carinii. J Infect Dis (1997) 1.60
Identification of a novel integrin binding site in fibronectin. Differential utilization by beta 3 integrins. J Biol Chem (1994) 1.60
The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion. Transfusion (2005) 1.60
Excess morbidity and mortality associated with influenza in England and Wales. Lancet (1980) 1.57
Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase. Int J Cancer (2000) 1.56
Hellenic holocaust: a historical clinico-pathologic conference. Am J Med (2000) 1.55
Histoplasmosis in immunosuppressed patients. Am J Med (1978) 1.54
Observations on the distribution of the proteinpolysaccharide complex and collagen in bovine articular cartilage. J Cell Sci (1967) 1.54
Substrate hydrolysis by matrix metalloproteinase-9. J Biol Chem (2001) 1.54
Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer. J Clin Oncol (1991) 1.53
Observations on the morphology of the proteinpolysaccharide complex of bovine nasal cartilage and its relationship to collagen. Proc R Soc Lond B Biol Sci (1966) 1.53
The beta-tubulin gene from rat and human isolates of Pneumocystis carinii. Mol Microbiol (1992) 1.52
Detection of Pneumocystis carinii DNA in air samples: likely environmental risk to susceptible persons. J Clin Microbiol (1997) 1.52
Mechanism of integrin activation by disulfide bond reduction. Biochemistry (2001) 1.51
Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology (2003) 1.51
Frequency of immediate adverse effects associated with apheresis donation. Transfusion (1998) 1.49
Experimental abortion and the systemic immune response to "Haemophilus somnus" in cattle. Infect Immun (1986) 1.48
Comparative evaluation of a modified zinc sulfate flotation technique. J Clin Microbiol (1978) 1.48
Pneumocystis carinii, an opportunist in immunocompromised patients. Clin Microbiol Rev (1991) 1.47
A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5. J Biol Chem (1995) 1.47
Molecular pattern in native collagen. Nature (1968) 1.47
Immediate breast reconstruction: reducing the risks. Plast Reconstr Surg (1989) 1.47
Treatment of cancer patients with ex vivo anti-CD3-activated killer cells and interleukin-2. J Clin Oncol (1993) 1.46
A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol (1983) 1.46
Survival of urinary leucocytes. J Clin Pathol (1966) 1.45
Comparison of six different PCR methods for detection of Pneumocystis carinii. J Clin Microbiol (1995) 1.45
Aflatoxicosis in the broiler chicken. Poult Sci (1970) 1.45
Evaluation of the protective value of hospital gowns against blood strike-through and methicillin-resistant Staphylococcus aureus penetration. Am J Infect Control (1998) 1.44
Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients. AIDS (1998) 1.44
Immunity of children to diphtheria, tetanus, and poliomyelitis. Br Med J (1979) 1.44
Viral arthritis. Ann Intern Med (1967) 1.43
Propionibacterium acnes: pathogen in central nervous system shunt infection. Report of three cases including immune complex glomerulonephritis. Am J Med (1976) 1.43
A hospital adverse drug reaction reporting program. Hospitals (1966) 1.42
Poliomyelitis surveillance in England and Wales, 1969-1975. J Hyg (Lond) (1978) 1.41
RedSoar--a system for red blood cell antibody identification. Proc Annu Symp Comput Appl Med Care (1991) 1.41
Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer (1990) 1.40
Tenure for a new age. Ideas for the turn of the century. Arch Intern Med (1989) 1.39
A phase II study of carboplatin, cisplatin, interferon-alpha, and tamoxifen for patients with metastatic melanoma. Cancer Invest (1998) 1.39
Diagnostic value of sinus-tract cultures in chronic osteomyelitis. JAMA (1978) 1.39
An empirical evaluation of the performance of antibody identification tasks. Transfusion (1991) 1.38
Effect of cross-immunization on monotypic antibody responses to herpes simplex virus types 1 and 2. J Immunol (1976) 1.37
Diphtheria and tetanus toxoids. Br Med Bull (1969) 1.36
Antigenic specificity of convalescent serum from cattle with haemophilus somnus-induced experimental abortion. Infect Immun (1987) 1.34